Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| minor |
APROKAM 50 mg, powder for solution for injection, provides a minor improvement in actual benefit (IAB IV) compared with standard management of postoperative endophthalmitis associated with cataract surgery. |
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
mxv3KardF0hscQm4
